Inovio Pharmaceuticals Inc (INO) Stock Analysis

Inovio Pharmaceuticals Inc (INO) is a publicly traded company in the HEALTHCARE sector. It trades at $1.21, carries a market capitalization of $105.31M. This page summarizes the public market data, fundamentals, and frequently asked questions for INO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.21
• Market Cap: $105.31M
• EPS: $-1.58
• 52-Week High: $2.98
• 52-Week Low: $1.03

Market Sentiment

Inovio Pharmaceuticals Inc currently has a Neutral sentiment score of -0.01.

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc. is a cutting-edge biotechnology company dedicated to developing innovative DNA-based therapeutics aimed at treating a range of diseases, including cancer and infectious diseases such as HPV. Leveraging its proprietary platform, Inovio stands at the forefront of immunotherapy advancements and has cultivated a diverse pipeline of product candidates designed to meet significant unmet medical needs. The firm’s ongoing clinical research initiatives reflect its commitmen...

GNG Research Analysis

GNG Research scores Inovio Pharmaceuticals Inc (INO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for INO.

Frequently Asked Questions

Does INO pay dividends?

Inovio Pharmaceuticals Inc (INO) does not currently pay a regular dividend.

What is INO's market cap?

Inovio Pharmaceuticals Inc (INO) has a market capitalization of $105.31M with a current stock price of $1.21.